Design Therapeutics, Inc. (DSGN) Operating cash flow 2020–2025
Design Therapeutics, Inc. (DSGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.4MFY2025 · since FY2020: -$8.7M → -$54.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.4M | -26.1% |
| FY2024 | -$43.1M | +26.4% |
| FY2023 | -$58.6M | -14.1% |
| FY2022 | -$51.3M | -74.7% |
| FY2021 | -$29.4M | -238.9% |
| FY2020 | -$8.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice